Correction: Mukherjee et al. Insights into the Scenario of SARS-CoV-2 Infection in Male Reproductive Toxicity. Vaccines 2023, 11, 510
- PMID: 39340118
- PMCID: PMC11435671
- DOI: 10.3390/vaccines12090996
Correction: Mukherjee et al. Insights into the Scenario of SARS-CoV-2 Infection in Male Reproductive Toxicity. Vaccines 2023, 11, 510
Abstract
The authors would like to make the following corrections to this published paper [...].
Erratum for
-
Insights into the Scenario of SARS-CoV-2 Infection in Male Reproductive Toxicity.Vaccines (Basel). 2023 Feb 22;11(3):510. doi: 10.3390/vaccines11030510. Vaccines (Basel). 2023. PMID: 36992094 Free PMC article. Review.
References
-
- Mukherjee A.G., Wanjari U.R., Gopalakrishnan A.V., Kannampuzha S., Murali R., Namachivayam A., Ganesan R., Renu K., Dey A., Vellingiri B., et al. Insights into the Scenario of SARS-CoV-2 Infection in Male Reproductive Toxicity. Vaccines. 2023;11:510. doi: 10.3390/vaccines11030510. - DOI - PMC - PubMed
-
- Piscoya A., Ng-Sueng L.F., Parra Del Riego A., Cerna-Viacava R., Pasupuleti V., Roman Y.M., Thota P., White C.M., Hernandez A.V. Efficacy and harms of remdesivir for the treatment of COVID-19: A systematic review and meta-analysis. PLoS ONE. 2020;15:e0243705. doi: 10.1371/journal.pone.0243705. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous
